Lv34
378 积分 2023-11-09 加入
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study
2小时前
已完结
TO MARKET, TO MARKET—2023: SMALL MOLECULES
10小时前
已完结
Covalency in PROTACs: Mechanisms and applications
13天前
已关闭
Next steps for targeted protein degradation
15天前
已完结
Harnessing conformational drivers in drug design
15天前
已完结
Safety and efficacy of antibody-drug conjugates plus immunotherapy in solid tumours: A systematic review and meta-analysis
24天前
已完结
The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development
27天前
已完结
KRAS degraders
30天前
已完结
Recent advances in the design of small molecular drugs with acrylamides covalent warheads
1个月前
已完结
To homeostasis and beyond! Recent advances in the medicinal chemistry of heterobifunctional derivatives
1个月前
已完结
皖公网安备34019202002308
